F. Dreyfus
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 3
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Bernard Rio (1 shared paper)Didier Blaise (1 shared paper)J L Pico (1 shared paper)D Maraninchi (1 shared paper)Éliane Gluckman (1 shared paper)Denis Guyotat (1 shared paper)V. Leblond (1 shared paper)Norbert Ifrah (1 shared paper)
In The Last Decade
F. Dreyfus
17 papers receiving 435 citations
Peers
Comparison fields: 5 of 41
- Hematology 315
- Genetics 104
- Immunology 151
- Pathology and Forensic Medicine 66
- Oncology 95
Countries citing papers authored by F. Dreyfus
This map shows the geographic impact of F. Dreyfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Dreyfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Dreyfus more than expected).
Fields of papers citing papers by F. Dreyfus
This network shows the impact of papers produced by F. Dreyfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Dreyfus. The network helps show where F. Dreyfus may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Dreyfus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 228 | |
| 2 | 1993 | 79 | |
| 3 | 2011 | 32 | |
| 4 | Prognostic value of c-mpl expression in myelodysplastic syndromes. | 1995 | 31 |
| 5 | Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. | 1990 | 27 |
| 6 | 1995 | 14 | |
| 7 | 1970 | 13 | |
| 8 | CDR3 size analysis of T cell receptor V beta transcripts: follow-up study in a patient with T cell acute lymphoblastic leukemia. | 1995 | 9 |
| 9 | 1993 | 5 | |
| 10 | 2011 | 4 | |
| 11 | 2011 | 2 | |
| 12 | Early involvement of the fim-2 and fim-3 regions in mouse myeloblastic leukemogenesis. | 1988 | 2 |
| 13 | 2013 | 2 | |
| 14 | [Abnormalities of the expression of cytokines and their receptors in myelodysplastic syndromes]. | 1997 | 2 |
| 15 | Maladie de Paget compliquée d'un lymphome Ki-1 avec sécrétion de facteur de croissance G-CSF | 1994 | 1 |
| 16 | 2017 | 1 | |
| 17 | 2011 | 1 | |
| 18 | 2007 | 0 |
About F. Dreyfus
F. Dreyfus is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Infectious Diseases, having authored 18 papers that have together received 453 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (315 citations), Genetics (104 citations), Immunology (151 citations), Pathology and Forensic Medicine (66 citations) and Oncology (95 citations). F. Dreyfus has collaborated with scholars based in France and Israel. Frequent co-authors include Bernard Rio, Didier Blaise, J L Pico, D Maraninchi, Éliane Gluckman, Denis Guyotat, V. Leblond, Norbert Ifrah, Mauricette Michallet and J Melle. Their work appears in journals such as Leukemia Research, Blood, The Lancet, Journal of Clinical Oncology and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.